Poor prognosis in breast cancer has been associated with elevated expression of the leptin receptor (LepR) and FGFR1 amplification, and co-expression of the FGFR1 gene and leptin protein copy number has been observed in primary breast tumours [121]. This evidence concerns the gene LEP and breast carcinoma.